Hepatitis B-Induced Hepatocellular Carcinoma: Understanding Viral Carcinogenesis and Disease Management
- PMID: 40217955
- PMCID: PMC11989475
- DOI: 10.3390/jcm14072505
Hepatitis B-Induced Hepatocellular Carcinoma: Understanding Viral Carcinogenesis and Disease Management
Abstract
Hepatitis B virus (HBV) infection is a leading cause of chronic liver disease and liver cancer worldwide. Hepatocellular carcinoma (HCC) remains one of the major causes of cancer-related mortality globally. Effective prevention and management strategies for HBV infection are crucial in reducing liver-related complications, including HCC. HBV plays a distinct role in liver carcinogenesis, and there is growing knowledge about the factors contributing to its oncogenic potential. With advancements in HCC management, special attention must be given to the treatment of HBV infection in patients with HBV-induced HCC. In this review, we summarize current insights into the carcinogenic mechanisms of HBV and discuss the latest approaches to managing HBV-induced HCC.
Keywords: antiviral therapy; hepatitis B virus (HBV); hepatocellular carcinoma (HCC).
Conflict of interest statement
The authors declare no conflict of interest related to this paper.
Figures
Similar articles
-
HBV-Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment.Liver Int. 2025 Jan;45(1):e16202. doi: 10.1111/liv.16202. Liver Int. 2025. PMID: 39720865 Free PMC article. Review.
-
Direct effects of hepatitis B virus-encoded proteins and chronic infection in liver cancer development.Dig Dis. 2013;31(1):138-51. doi: 10.1159/000347209. Epub 2013 Jun 17. Dig Dis. 2013. PMID: 23797136 Review.
-
The dual role of regulatory T cells in hepatitis B virus infection and related hepatocellular carcinoma.Immunology. 2024 Apr;171(4):445-463. doi: 10.1111/imm.13738. Epub 2023 Dec 14. Immunology. 2024. PMID: 38093705 Review.
-
Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic.Curr Cancer Drug Targets. 2017;17(6):505-511. doi: 10.2174/1568009616666160926124530. Curr Cancer Drug Targets. 2017. PMID: 27677954 Review.
-
Hepatocellular carcinoma: The virus or the liver?Liver Int. 2023 Aug;43 Suppl 1:22-30. doi: 10.1111/liv.15253. Epub 2022 Mar 29. Liver Int. 2023. PMID: 35319167 Review.
References
-
- Katamba C., Onaluwa Philippe O. Epidemiology of Hepatitis B Virus. In: Rodrigo L., editor. Hepatitis B. IntechOpen; Rijeka, Croatia: 2021.
-
- Alberts C.J., Clifford G.M., Georges D., Negro F., Lesi O.A., Hutin Y.J., de Martel C. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: A systematic review. Lancet Gastroenterol. Hepatol. 2022;7:724–735. doi: 10.1016/S2468-1253(22)00050-4. - DOI - PMC - PubMed
-
- Center for Disease Control and Prevention Hepatitis B Surveillance. [(accessed on 1 February 2025)];2021 Available online: https://www.cdc.gov/hepatitis/statistics/2021surveillance/hepatitis-b.htm.
-
- World Health Organization Hepatitis B. [(accessed on 1 February 2025)]. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
Publication types
LinkOut - more resources
Full Text Sources